Effects of IL-1 Beta on the Hypothalamic-pituitary-adrenal (HPA) Axis in Obese Persons - the CortIL-Study

Trial Profile

Effects of IL-1 Beta on the Hypothalamic-pituitary-adrenal (HPA) Axis in Obese Persons - the CortIL-Study

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2016

At a glance

  • Drugs Anakinra (Primary)
  • Indications Metabolic syndrome
  • Focus Therapeutic Use
  • Acronyms CortIL
  • Most Recent Events

    • 22 Aug 2016 Status changed from recruiting to completed.
    • 07 Apr 2016 Planned number of patients changed from 69 to 76 as reported by ClinicalTrials.gov record.
    • 19 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top